47 results on '"Iwasaki, Akiko"'
Search Results
2. Post-Vaccination Syndrome: A Descriptive Analysis of Reported Symptoms and Patient Experiences After Covid-19 Immunization
3. Setdb1-loss induces type-I interferons and immune clearance of melanoma
4. Cancer relevance of circulating antibodies against LINE-1 antigens in humans
5. High titers of infectious SARS-CoV-2 in COVID-19 corpses
6. Distinguishing features of Long COVID identified through immune profiling
7. SARS-CoV-2 variants do not evolve to promote further escape from MHC-I recognition
8. Effectiveness of Primary and Booster COVID-19 mRNA Vaccination against Omicron Variant SARS-CoV-2 Infection in People with a Prior SARS-CoV-2 Infection
9. Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu
10. Inhalable polymer nanoparticles for versatile mRNA delivery and mucosal vaccination
11. Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration
12. Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses
13. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain
14. A synthetic bispecific antibody capable of neutralizing SARS-CoV-2 Delta and Omicron
15. Immunogenicity of heterologous BNT162b2 booster in fully vaccinated individuals with CoronaVac against SARS-CoV-2 variants Delta and Omicron: the Dominican Republic Experience
16. No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination
17. LINE-1 activation in the cerebellum drives ataxia
18. De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report
19. Inflammasome activation in infected macrophages drives COVID-19 pathology
20. Development and utilization of a surrogate SARS-CoV-2 viral neutralization assay to assess mRNA vaccine responses
21. Mutations in two SARS-CoV-2 variants of concern reflect two distinct strategies of antibody escape
22. Change in Symptoms and Immune Response in People with Post-Acute Sequelae of SARS-Cov-2 Infection (PASC) After SARS-Cov-2 Vaccination
23. High-affinity, neutralizing antibodies to SARS-CoV-2 can be made in the absence of T follicular helper cells
24. Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
25. Plasmodium infection induces cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein
26. Associations of SARS-CoV-2 serum IgG with occupation and demographics of military personnel
27. PD-1highCXCR5–CD4+ Peripheral Helper T (Tph) cells Promote Tissue-Homing Plasmablasts in COVID-19
28. Impact of B.1.1.7 variant mutations on antibody recognition of linear SARS-CoV-2 epitopes
29. Immunologically distinct responses occur in the CNS of COVID-19 patients
30. Single-cell longitudinal analysis of SARS-CoV-2 infection in human bronchial epithelial cells
31. Exploratory neuroimmune profiling identifies CNS-specific alterations in COVID-19 patients with neurological involvement
32. Generating hard-to-obtain information from easy-to-obtain information: applications in drug discovery and clinical inference
33. Clinical Characteristics and Outcomes for 7,995 Patients with SARS-CoV-2 Infection
34. Neuroinvasion of SARS-CoV-2 in human and mouse brain
35. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
36. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium
37. SARS-CoV-2 infection of the placenta
38. PD-1 blockade-driven anti-tumor CD8+ T cell immunity requires XCR1+ dendritic cells
39. Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs
40. Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR primer-probe sets
41. Coast-to-coast spread of SARS-CoV-2 in the United States revealed by genomic epidemiology
42. Antibody against envelope protein from human endogenous retrovirus activates neutrophils in systemic lupus erythematosus
43. The lupus susceptibility locus Sgp3 encodes the suppressor of endogenous retrovirus expression SNERV
44. Human APOBEC3G prevents emergence of infectious endogenous retrovirus in mice
45. Innate Immune Priming by cGAS as a Preparatory Countermeasure Against RNA Virus Infection
46. Microbiota-independent antiviral protection conferred by aminoglycoside antibiotics
47. A minimal RNA ligand for potent RIG-I activation in living mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.